AveGene tests are based on Liquid Biopsy using a blood sample (plasma). This method can identify somatic variants in circulating cell-free tumor DNA (ctDNA).
A safe, non-invasive, sensitive, and economical technique for examining circulating tumor DNA (ctDNA) from the plasma of customers or those who may have the disease is called a “liquid biopsy.”
Through the examination of ctDNA extracted from a patient’s blood, we are able to detect genetic changes in ctDNA that are clinically significant and correlate these changes with specific treatments and clinical studies.
Viruses are intracellular parasites that replicate using the cell's internal environment and organelles. During a viral infection of a cell, a viral particle (occasionally only a portion; always the viral genetic information) invades the cell, exposes the viral genetic information, and initiates the expression of this information.
Various viruses have various replication requirements, and their replication mechanisms are also distinct (for instance, DNA and RNA viruses exhibit the most striking differences). Regardless, viral genetic information and viral proteins are external molecules that can interact with both cellular proteins and the cellular genome. This interaction can have numerous effects, including the initiation of the malignant (cancer) transformation process.
Heavy metals have technically the same effect on human body. Knowing the body contamination / infection is essential in cancer disease prevention.
At AveGene, we have implemented and responsibly use artificial intelligence (AI) and machine learning (ML). Both significantly improve the efficiency and accuracy of our company’s processes, particularly when processing large amounts of data, identifying patterns, and providing valuable clinical insights."
Please check that you have obtained the appropriate Sample Collection and Transportation Kit(s) for the screenings you required.
HPV sample collection and transportation Kit. Its is intended for collection and shipment of urine specimen. This test kit is only compatible with HPV tests for male and female.
The "AveGene ct/cfDNA liquid biopsy somatic & germinal mutations sample collection & transport kit" contains special vials with a solution that preserves blood for up to 14 days at room temperature. This kit is intended for venous blood collection at your nearest doctor's office or healthcare center. It also includes transport components into which you will package the blood after collection and send it to the nearest AveGene collection center. This kit is compatible with all types of our screening oncological tests, hereditary cancer risk test, and heavy metals test. These tests can be freely combined from a single sample.
Learn more about cf/ctDNA Liquid biopsy.
This sample collection kit is fully compatible with following tests:
Qualitative in vitro screening test from urine detecting 14 high-risk (HR) HPV genotypes at clinically relevant Infection levels in general and vaccinated pupulation. As the most common sexually transmitted infection, HPV affects nearly 80% of people during their lives, often without showing symptoms. This screening test empowers you to understand your HPV status, enabling proactive health management and reducing the risk of serious health conditions.
Liquid biopsy screening test, designed to effectively and without intervention analyze blood samples to provide comprehensive tumor profiling, focusing on clinically relevant content. Cancer is one of the most leading cause of death in the world. Symptoms are often equivocal and can be easily overlooked. Increasing number of cancers can be treated but It is important to diagnose it at the earliest possible stage, while it increases the survival rate.
A highly sensitive liquid biopsy screening test designed for effective, non-invasive blood sample analysis. The panel is primarily tailored for colorectal (CRC) and lung cancer screening, while also including a selected spectrum of other major oncogenes relevant across important solid tumours. CRC and lung cancer are among the most common cancers worldwide, yet their early symptoms are often subtle and easily overlooked. As cancer treatment continues to advance, early detection remains critical, because diagnosis at the earliest possible stage can significantly improve survival outcomes.
-
1Register and get your kit. Sign the screening form in the Client Zone and choose your physician for the indication. Get your kit from your physician, a pharmacy or a distributor.
-
2Give your sample. Any authorised healthcare professional can draw your blood. Urine for HPV screening you collect at home - only for HPV and Heavy Metals screening.
-
3Send it by courier. Use the transport box in your kit to send the sample to our laboratory or a collection centre. We check DNA quality on arrival.
-
4Get your report. With your consent and indication confirmed, we sequence your sample. We e-mail you when your report is ready in the Client Zone.
-
5Discuss it with your physician. Your report has a plain-language part for you and a detailed part for your physician, who decides on next steps.
Learn more about the reports and how it should be understood. Please keep in mind the results shall always be consulted with your Medical Doctor who knows your physical status. This screening program shall act as an early detection alert. We do not provide diagnostics!
